At the initiation of therapy with carbamazepine or other known cyp 3a4 hepatic enzyme inducers, patients should be closely monitored during the first 4-8 weeks, since the dose of risperdal consta may need to be adjusted.
At the initiation of therapy with carbamazepine or other known cyp 3a4 hepatic enzyme inducers, patients should be closely monitored during the first 4-8 weeks, since the dose of risperdal consta may need to be adjusted.